We have observed
6 EP applications
Carin Marie Lisa Ribard
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after September 12, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
USE OF ANTI-CD19 MAYTANSINOID IMMUNOCONJUGATE ANTIBODY FOR THE TREATMENT OF B-CELL MALIGNANCIES SYMPTOMS
PROCESS FOR PREPARING GENETICALLY TRANSFORMED YEASTS CAPABLE OF PRODUCING A MOLECULE OF INTEREST AT A HIGH TITRE
COMBINATION THERAPY FOR THE TREATMENT OF CD19+ B-CELL MALIGNANCIES SYMPTOMS COMPRISING AN ANTI-CD19 MAYTANSINOID IMMUNOCONJUGATE AND RITUXIMAB
A MIXTURE OF POLAR GLYCOLIPIDS FOR USE IN THE TREATMENT OF PAIN AND COPD
IMMUNO IMAGING AGENT FOR USE WITH ANTIBODY-DRUG CONJUGATE THERAPY
NOVEL CYTOCHROME P450 POLYPEPTIDE WITH INCREASED ENZYMATIC ACTIVITY